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Abstract
Background: The immune response to trauma has traditionally been modeled to consist of the systemic
inflammatory response syndrome (SIRS) followed by the compensatory anti-inflammatory response syndrome
(CARS). We investigated these responses in a homogenous cohort of male, severe blunt trauma patients admitted
to a University Hospital surgical intensive care unit (SICU). After obtaining consent, peripheral blood was drawn up
to 96 hours following injury. The enumeration and functionality of both myeloid and lymphocyte cell populations
were determined.
Results: Neutrophil numbers were observed to be elevated in trauma patients as compared to healthy controls.
Further, neutrophils isolated from trauma patients had increased raft formation and phospho-Akt. Consistent with
this, the neutrophils had increased oxidative burst compared to healthy controls. In direct contrast, blood from
trauma patients contained decreased naïve T cell numbers. Upon activation with a T cell specific mitogen, trauma
patient T cells produced less IFN-gamma as compared to those from healthy controls. Consistent with these
results, upon activation, trauma patient T cells were observed to have decreased T cell receptor mediated signaling.
Conclusions: These results suggest that following trauma, there are concurrent and divergent immunological
responses. These consist of a hyper-inflammatory response by the innate arm of the immune system concurrent
with a hypo-inflammatory response by the adaptive arm.
Background
Inflammation can be detected following trauma, even in
the absence of infection, due to a global ischemia/reper-
fusion injury resulting in the systemic inflammatory
response syndrome (SIRS). SIRS is diagnosed clinically
when patients have more than one of the following clin-
ical findings: significant changes in body temperature,
tachycardia, tachypnea, or white blood cell count of
>12,000 cells μL
-1 or <4,000 μL
-1[1]. This hyper-inflam-
matory response can be further characterized by
increased expression of inflammatory mediators such as
pro-inflammatory cytokines, acute phase proteins, and
complement that result in leukocyte activation and
extravasation from the vascular compartment into
surrounding tissues (reviewed in [2]). Additionally, num-
bers of neutrophils in the periphery increase, as does the
priming of these cells [3,4]. Increased neutrophil num-
bers and activation can lead to bystander tissue damage
with increased complications upon subsequent infection
[5]. Recently, key structural elements of priming have
been identified. Priming results in the formation of
supramolecular complexes, which can include an array
of receptors, structural proteins, and components of the
nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase. These form on detergent-resistant membrane
fragments called rafts, which are specialized membrane
elements enriched in glycosphingolipids, cholesterol, and
anti-apoptotic active Akt [6]. This proximity allows for
close coupling of receptor mediated signaling, effector
function, and crosstalk between surface receptors and
downstream signaling systems [7]. * Correspondence: charles.caldwell@uc.edu
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drome (CARS) is proposed to follow SIRS in trauma
patients. In the innate arm of the immune system,
CARS can be characterized in patients exhibiting reduc-
tions in monocyte HLA-DR expression or ex vivo tumor
necrosis factor alpha production [8]. In the adaptive arm
of the immune system, CARS is characterized by a
blunted response to infections due to decreased T cell
n u m b e r sa sw e l la sm i t o g e nu n r e s p o n s i v e n e s s[ 9 , 1 0 ] .T
cell apoptosis is responsible for declining T cell num-
bers following trauma [10,11]. Mitogen unresponsive-
ness after injury results in both reduced T cell cytokine
production and decreased protein phosphorylation fol-
lowing T cell receptor-mediated stimulation [12,13].
Altogether, decreases in T cell numbers and responsive-
ness are thought to predispose trauma patients to noso-
comial infections, sepsis, and multiple organ dysfunction
[14,15].
These studies strongly suggest that trauma-induced
changes to the immune system can predispose the
patient to subsequent adverse clinical events, especially
in the event of an infection. Currently, there are multi-
ple therapies known to up or down regulate inflamma-
tion and the immune system [16]. Ideally, therapies
should protect all cellular host defense compartments
from hyper-inflammation, as well as from anergy. How-
ever, the response to trauma is dynamic and there exists
an e e dt oe f f e c t i v e l ym o n i t o rt h ei m m u n es t a t u so f
patients in order to properly modulate inflammation.
In recent years there has been recognition that new
approaches are needed for determination of the immune
capacity of patients following trauma. Here, we enrolled
a cohort of blunt trauma patients that was relatively
homogenous in terms of sex, age, severity of injury, and
mode of injury. We concurrently examined cells in both
the innate and adaptive arms of the immune system in
these patients in terms of absolute leukocyte numbers
and function. Further, mechanisms underlying cell func-
tionality were investigated. To our knowledge, this is the
first report of a homogeneous cohort of trauma patients
used to concurrently examine the function and mechan-
isms of both the innate and adaptive immune systems.
Results
Blunt trauma patient characteristics
There was no significant age difference between male
blunt trauma patients enrolled in this study (36.3 ± 2.4
years) and healthy controls (37.8 ± 2.2 years). A mean
Injury Severity Score (ISS) of 22.8 for all patients was
calculated. 59% of patients requiring blood transfusion
due to traumatic injury received an average of 1408 ml
(± 552) packed red blood cells (PRBCs). 27% of patients
were intubated at some point during their hospital stay
(intubation strictly for operative intervention not
included) and remained mechanically ventilated for an
average of 14.2 (± 4.5) days. More than 85% of patients
involved in this study underwent at least one surgical
intervention. Those patients receiving at least one
operation underwent an average of 2.6 (± 0.4) interven-
tions during their admission. Total hospital length of
stay for all patients in this study was 17.4 (± 2.2) days.
Further characteristics of the patient population, includ-
ing mean admission vital signs and lab values, are
described in Table 1.
Neutrophil numbers and function are increased following
blunt trauma
It has been observed that following trauma the propor-
tion and absolute numbers of peripheral leukocytes can
be altered. Here, in Figure 1a, we observed a 2-5 fold
increase in circulating neutrophils out to five days post-
trauma. Additionally, using b2-integrin (CD11b) as an
activation marker, we observed significantly increased
Table 1 Blunt Trauma Patient Characteristics
Age (Years) 36.3 ± 2.4
Injury Severity Score (ISS) 22.8 ± 2.1
Admission Temperature (°F) 97.9 ± 0.3
Admission Heart Rate 107 ± 5
Admission Systolic Blood Pressure 113 ± 5
Admission Diastolic Blood Pressure 72 ± 4
Admission Respiratory Rate 20 ± 1
Hemoglobin Concentration 9.0 ± 0.4
Platelet Count 145 ± 15
International Normalized Ratio (INR) 1.3 ± 0.1
Base Deficit 4.9 ± 1
Average Volume of PRBCs Transfused per Patient Requiring Transfusion (ml) 1408 ± 552
Average Number of Operations per Patient Requiring an Operation 2.6 ± 0.4
Average Number of Ventilator Days in Patients Requiring Intubation 14.2 ± 4.5
Hospital Length of Stay (Days) 17.4 ± 2.2
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1b) out to four days post trauma. Thus, neutrophil
numbers and activation are significantly higher following
blunt trauma.
Although we determined that neutrophils demon-
strated an activated phenotype, we further investigated
whether the neutrophils had increased functionality.
Therefore, oxidative burst was evaluated in trauma ver-
sus control patients that were representative of those in
Figure 1 in terms of ISS and age (Figure 2a). Here, neu-
trophils from the blunt trauma patients had a significant
increase in fMLP-stimulated activity versus those neu-
trophils from controls. Additionally, we directly
observed via confocal microscopy the increased oxida-
tive burst in fMLP treated cells isolated from trauma
patients as compared to healthy controls (Figure 2b).
Thus, neutrophils isolated from trauma patients showed
increased activation and functionality.
Following trauma, there is an observed increase in
pro-inflammatory cytokines, which may act to prime
neutrophils. It has been reported that neutrophil prim-
ing involves the localization of activated CD11b within
lipid rafts as well as increased phosphorylated Akt[7].
To investigate if this occurred within our cohort of
patients, we isolated raft and non-raft fractions from
purified neutrophils and probed for active CD11b (Fig-
ure 3a). Here, we found significantly more CD11b in
neutrophil rafts from trauma patients as compared to
controls. Additionally, we observed increased phos-
phorylated-Akt, but not -ERK or -p38, in neutrophils
isolated form trauma patients (Figure 3b). These data
indicate the neutrophils of trauma patients are primed,
functionally more activated, and likely more resistant to
apoptosis as compared to controls.
T cell numbers and function are reduced following blunt
trauma
The studies above investigated the innate response of
the immune system to blunt trauma. Here, we contin-
ued our investigations by concurrently examining the
response of the adaptive immune system in the same
cohort of male blunt trauma patients and healthy con-
trols. Flow cytometric analysis revealed that absolute
numbers of peripheral naïve CD4 and CD8 T-cells from
trauma patients were significantly decreased as com-
pared to controls (Figure 4a and 4b). Temporally, the
naive subtypes were observed at approximately 50% of
the control values. Additionally, significant differences
were observed in non-naïve T cells, though percentage
differences were less stark than those of the naïve T cell
populations. Thus, in a homogeneous cohort of blunt
trauma patients, peripheral T cell numbers are rapidly
decreased and remain decreased for at least 4 days fol-
lowing injury.
IFN-g is a potent activator of neutrophils and macro-
phages, and plays a key role in combating infections
[18,19]. In our present study, we activated equal
Figure 1 Human circulating neutrophil numbers and activation are both increased following blunt trauma. Results were obtained after
collection of blood and flow cytometric analysis as described in the methods. (A) Absolute numbers of neutrophils are significantly increased
following trauma. (B) Neutrophil activation is initially and remains increased following trauma. Data represents group size of 15 controls and 6, 7,
and 9 blunt trauma patients at respective timeframes. *, p ≤ 0.05 versus controls. **, p ≤ 0.01. ***, p ≤ 0.001.
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Page 3 of 9Figure 2 Oxidative burst increased in blunt trauma following fMLP stimulation. After specimen collection, neutrophils were stimulated and
H2O2 production measured as described in the methods. (A) In comparison to controls, blunt trauma patients show increased oxidative burst
activity. (B) Representative photographs of fMLP activated neutrophils were obtained demonstrating increased Dihydroxyrhodamine in a
neutrophil from a blunt trauma patient at 48-72 h post injury. Data represents group size of 3 controls and 3 blunt trauma patients during the
48-72 h timeframe. *, p ≤ 0.05 versus controls. **, p ≤ 0.01.
Figure 3 Blunt trauma patients show increased percentage of activated CD11b within rafts, along with an elevated p-AKT. (A) CD11b
rafts of blunt trauma patients demonstrate a higher percentage of CD11b within rafts relative to controls with similar results demonstrated by
western blot. (B) Phosphorylated (p)-AKT following blunt trauma is markedly elevated compared to controls, while p-ERK and p-p38 are similar
between groups. Data represents group size of 4 controls and 4 blunt trauma patients during the 48-72 h timeframe. *, p ≤ 0.05 versus control.
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trauma patients 40-96 hours after injury together with
age- and sex-matched controls using T cell specific
mitogens for 48 hours and analyzed for IFN-g accumula-
tion (Figure 5). Here, we found trauma patients had sig-
nificantly decreased IFN-g production as compared to
healthy controls.
In Figure 5, we show that T cells from trauma patients
have reduced immune function. Previous reports have
suggested that deficiencies in TCR-mediated signaling
may result in decreased T cell-specific cytokine produc-
tion [9]. The recent availability of phosphorylation-spe-
cific antibodies adapted for flow cytometry allowed us to
determine on a single cell basis early activation events.
The TCR-ab or TCR-gδ and CD3, form the TCR-CD3
complex, which allows for antigen recognition and effec-
tive immune system functionality. The activation of this
complex can be observed by the phosphorylation of
immunoreceptor tyrosine-based activation motif (ITAM)
t y r o s i n e st h a ta r el o c a t e do nt h eT C R - ζ chain (CD247).
Analysis of IFN-g accumulation data demonstrated two
distinct groups within our blunt trauma cohort that we
stratified as those with low IFN-g production and those
not significantly different from healthy controls. We
next wanted to determine whether these differences
might be due to alterations in TCR mediated signaling.
The phosphorylated CD247 (pCD247) expression was
determined in these three subgroups (Figure 6). Here,
we demonstrate that pCD247 expression was approxi-
mately 30% lower in the low IFN-g producing group as
compared to the other two groups. Thus, in patients
whose T cell IFN-g production is decreased, reduced
TCR-mediated signaling is also demonstrated.
Discussion
In our present study, we generated a cohort of trauma
patients that was homogeneous in terms of sex, age,
severity of injury, and mode of injury. Additionally, we
Figure 4 Human circulating T cell numbers are decreased following blunt trauma. Absolute numbers of (A) Naïve CD4, (B) Naïve CD8, (C)
Effector CD4, and (D) Effector CD8 T cell populations were obtained by flow cytometric analysis as described in the methods section. Data
represents group size of 15 controls and 6, 7, and 9 blunt trauma patients at respective timeframes. *, p ≤ 0.05 versus controls. **, p ≤ 0.01.
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tive arms of the immune system in this cohort of
patients by determining the cell absolute numbers as
well as function. Further, the mechanism underlying the
function was determined. We believe that the combina-
tion of these three aspects make this a unique study.
In general, the immunological response to trauma has
been modeled as a systemic inflammatory response fol-
lowed sequentially by compensatory anti-inflammatory
response. In our study, one aspect of SIRS, the increase
in neutrophil priming and numbers, was observed up to
96 hours following trauma. One characteristic of CARS
is reduced T cell numbers and impaired immune func-
tion. We also observed this phenomenon. However, this
was seen almost immediately and up to 96 hours follow-
ing trauma. Thus, aspects of SIRS and CARS were seen
concurrently for a fairly prolonged period of time. Alto-
gether, we believe that presence of both hyperactive
neutrophils and anergic T cells needs to be considered
when attempting to modulate the immune system fol-
lowing trauma so to beneficially modulate the subse-
quent response to adverse clinical events such as acute
respiratory distress syndrome (ARDS), VAP and oppor-
tunistic infections.
This and previous studies [10] have demonstrated that
trauma can lead to a decrease in the T cell numbers.
While possible reasons for this decline include the
effects from transfusion, dilution from resuscitation and
movement from periphery, based on numerous studies,
we feel apoptosis is the underlying cause of the decline
[20,21]. The end result of massive naïve T cell apoptosis
would include immunosuppression due to a loss of the
TCR repertoire able to respond to subsequent infec-
tions, along with production of anti-inflammatory med-
iators by macrophages during phagocytosis of apoptotic
bodies [22]. Further, the loss of T cell-mediated IFN-g
production serves to limit the activation of the innate
immune system.
Figure 6 The degree of CD247 phosphorylation is associated with bifurcated IFN-g production in blunt trauma patients. Representative
flow cytometry (A) of CD247 phosphorylation in controls versus trauma patients with low and normal IFN-g production. Mean fluorescence
intensity (MFI) of CD247 phosphorylation (B) in control patients versus low-IFN-g producers and normal IFN-g producers. Data represents group
size of 11 controls and 4-5 blunt trauma patients at 48-96 h post injury. *, p ≤ 0.05 versus controls.
Figure 5 IFN-g production decreased in trauma patients.
Peripheral leukocytes were collected and then stimulated with
cross-linked, soluble anti-CD3 and anti-CD28. After 48 hours, the cell
culture supernatant was collected with IFN-g concentration
determined by ELISA. Data represents group size of 11 controls and
9 blunt trauma patients at 48-96 h post injury. *, p ≤ 0.05 versus
controls.
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profound effects on T cell function. Within the TCR/
CD3 complex are ITAMS which become phosphorylated
during antigen-driven T cell activation. However, the
degree of phosphorylation determines the degree of T
cell activation. For example, a single ITAM phosphory-
lation activates SHP [23]. SHP expression is increased
following trauma and its actions are known to be inhibi-
tory [24]. Yet, two ITAM phosphorylations will result in
full T cell activation [23]. Thus, we believe the differ-
ences observed in CD247 phosphorylation are, in part,
responsible for the differences in IFN-g production.
Whether these differences are due to increased phos-
phatase activity or decreased gene expression is cur-
rently under investigation.
The T cell specific studies indicate that of the patients
tested for IFN-g production and CD247 phosphoryla-
tion, there were two fairly distinct groups. When com-
p a r e dt oh e a l t h yc o n t r o l s ,o n eg r o u ps h o w e dn o
significant differences in IFN-g production and CD247
phosphorylation, while the other group showed signifi-
cant decreases in each. Both groups had no significant
differences in injury severity scores (25 versus 21,
respectively) or age (32.4 versus 31.5 years, respectively).
However, the hospital length of stay was trending
towards an increase for those patients with poor T cell
function (20.8 versus 12.3 days, p = 0.08). Whether or
not these assays will be more predictive of adverse clini-
cal events is an ongoing investigation.
Our data show that the function and numbers of
neutrophils are increased following blunt trauma (Fig-
ure 1). Associated with this is increased phosphory-
lated Akt (Figure 3b). Active Akt is known to both
decrease apoptosis as well as increase the oxidative
burst [25,26]. The excessive number of these hyperac-
tive cells can lead to excessive tissue damage, further
worsening the condition of some trauma patients.
Additionally, it has been shown that phosphorylated
Akt can be prognostic for poor clinical outcomes [27].
We hypothesize that Akt has increased phosphoryla-
tion due to increased systemic IL-6 observed following
trauma. Increased IL-6 can lead to increased tyrosine
kinase activity by Jak-1 and -2 [28]. A potential tyro-
sine phosphorylation target of Jak-2 is PP2a [29].
When tyrosine-307 is phosphorylated, PP2a assembly
as well as activity might selectively be inhibited [30].
This is important, as Akt is known to be de-phos-
phorylated by PP2a (reviewed in [31]). Although other
mediators can activate Jak2, we believe IL-6 represents
a likely candidate for future studies.
Although this study demonstrates new insights regard-
ing the response of human T-cells to blunt trauma, it
has limitations. First, we may not be measuring the
whole of the immune compartment through our current
methodology. For example, T cell numbers were not
measured in the thymus, spleen or lymph nodes. Sec-
ondly, blunt trauma is wide-ranging and the effect of
different mechanisms may play a role in the changes
seen in this study. Even patients with non-significant
differences in injury severity scores can have vastly dif-
ferent outcomes based on mechanism.
Conclusion
In summary, our study demonstrates that there is a
complex response of the innate and adaptive immune
system quickly following trauma. We believe that this
report distinguishes itself from other reports in that a
very homogeneous cohort of patients was used. Addi-
tionally, both the innate and adaptive responses were
numerically, functionally, and mechanistically examined
concurrently. Altogether, these results demonstrate that
there is a simultaneous and divergent immunological
response to trauma. This consists of a hyper-inflamma-
tory response by the innate arm of the immune system,
while there is a hypo-inflammatory response by the
adaptive arm. We believe that this concurrent diver-
gence will need to be taken in consideration for thera-
peutic interventions.
Methods
Informed Consent/Patient Enrollment
In this study, 22 male blunt trauma patients and 15
healthy male subjects were enrolled over a period of 18
months (January 2007 through June 2008). Approval for
human subject research was gained from the University
of Cincinnati Institutional Review Board (protocol # 06-
03-07-06). Written informed consent from the patient
or patient representative and healthy control volunteers
was received prior to obtaining blood samples. Patients
were selected for inclusion based on the following cri-
teria: (1) blunt trauma between the ages of 18 and 55,
(2) admitted to the surgical intensive care unit, (3) no
clinical evidence of immunosuppression and on no
immunosuppressive medication, and (4) no clinical sus-
picion of sepsis.
Peripheral Blood Isolation
Venous blood was drawn from patients and volunteer
controls concurrently and placed into glass blood tubes
with EDTA. Blood was drawn once at 09:00 am the day
following enrollment. Serial blood draws from the same
patient on subsequent days were not obtained. 6 patient
samples were within the 24-48 h timeframe; 7 patient
samples were within the 48-72 h timeframe; 9 patient
samples were within the 72-96 h timeframe. Red blood
cells were removed by placement of individual samples
into lysis buffer (BD Pharmingen, San Diego, CA) for 10
minutes. After lysis, cells were prepared for flow cyto-
metry as described below.
Kasten et al. BMC Immunology 2010, 11:4
http://www.biomedcentral.com/1471-2172/11/4
Page 7 of 9Adherence Dependent Oxidative Response Assay
Ninety six-well polystyrene tissue culture dishes were
coated with 1 μg/well fibronectin for two hours at 37°C
and 5% CO2 and then washed. 100 μl of reaction mix-
ture (10 mM scopoletin, 1 mg/ml horseradish peroxi-
dase, 4 mM NaN3 in KRPG) and 20 μln e u t r o p h i l s
resuspended in KRPG at 7.5 × 10
5 cells/ml were allowed
to incubate 10 minutes at 37°C in the wells prior to sti-
mulation with either buffer or fMLP (100 nM). Fluores-
cence was measured immediately and at ten-minute
intervals for 80 minutes. H2O2 production was calcu-
lated from the decrease in fluorescence due to the oxi-
dation of scopoletin. The data are expressed as
nanomoles of H2O2 produced per 1.5 × 10
4 PMNs.
Adherence Dependent Oxidative Burst Imaging with
Dihydroxyrhodamine
Peripheral leukocytes were loaded with dihydroxyrhoda-
mine in HBSS in a 37°C water bath for 5 minutes. Cells
were allowed to adhere to fibronectin coated μ-slide
(ibidi-Integrated BioDiagnostics, Munchen, Germany)
for 10 min at 37°C in 5% CO2. A 488 laser line with a
band pass filter (505-550) was used to track the oxida-
tion of dihydroxyrhodamine (Invitrogen, Carlsbad, CA)
to rhodamine123. The image was captured with an
inverted confocal microscope. Digital zoom equals 1.8×.
After baseline images were captured 100 nm fMLP was
added with recapture of images.
Lipid Raft Fractionation and Western Blotting
PMN membrane protein (250 μg) was lysed for 30 min
with 0.5 mls ice-cold 1% Brij 97 (Sigma-Aldrich, St.
Louis, MO) plus 1 μg/ml leupeptin and pepstatin, 1 mM
orthovanadate and 0.2 mM PMSF (Sigma-Aldrich, St.
Louis, MO). The resulting lysate was mixed with 0.7 ml
80% sucrose and loaded into 4 ml Beckman SW 56 cen-
trifuge tubes, overlaid with 2 ml of 35% sucrose, and 1
ml of 5% sucrose. Equilibrium centrifugation was per-
formed at 200,000 × g, 4°C for 18 hours. Ten 0.4 ml
fractions were collected from the top of the gradient.
Lipid rafts were determined by dot blot analysis using
HRP conjugated cholera toxin B (CTX-B). Equal
volumes of lipid raft or non-raft fractions were resolved
by 10% SDS-PAGE and transferred to nitrocellulose
membranes. Membranes were probed overnight at 4°C
with antibody to CD11b. Bands were visualized using
chemiluminescence and autographic film.
Leukocyte Identification and Enumeration by Flow
Cytometric Analysis
Single-cell suspensions were prepared using standard pro-
cedures as previously described [17]. Cell counts were
determined using a Beckman-Coulter AcT 10 cell counter.
Cells were stained with the following: PB CD4 (Caltag,
C a r l s b a d ,C A ) ,P BC D 8( C a l t a g ,C a r l s b a d ,C A ) ,P e r C P
CD3 (BD Pharmingen, San Diego, CA), FITC CD45RA
(Clone: JS-83; eBioscience, San Diego, CA), PE CD45RO
( B DP h a r m i n g e n ,S a nD i e g o ,C A ) ,P EC D 1 1 b( C l o n e :
1CRF44; eBioscience, San Diego, CA) and PB CD16
( C l o n e :3 G 8 ,B DP h a r m i n g e n ,S a nD i e g o ,C A ) .C D 4a n d
CD8 naïve subsets were defined by CD45RA-positive
staining. CD4 and CD8 effector subsets were identified by
CD45RO-positive staining. Flow cytometry data acquisi-
tion and analysis were performed on an LSR II using
FACS Diva software (BD Pharmingen, San Diego, CA).
Neutrophil phospho-Erk, -p38, and -Akt Expression
Determined by PhosFlow Analysis
Neutrophils were stained with PE CD11b (Clone:
1CRF44; eBioscience, San Diego, CA) and FITC phos-
pho-Erk (Thr202/Tyr204; Cell Signaling, Boston, MA),
Alexa Fluor 647 phospho-p38 (T180/Y182; Cell Signal-
ing, Boston, MA), or FITC phospho-Akt (Ser473; Cell
Signaling, Boston, MA) fluorescently labeled antibodies.
Flow cytometry data acquisition and analysis were per-
formed on LSR II using FACS Diva software (BD Phar-
mingen, San Diego, CA).
T-Cell phospho-CD247 Expression Determined by
PhosFlow Analysis
T Cells were activated using soluble anti-CD3 (Clone:
UCHT1; BD Pharmingen, San Diego, CA) and anti-
CD28 (Clone: CD28.2; BD Pharmingen, San Diego, CA)
cross-linked with secondary antibody for 5 minutes. Par-
aformaldehyde was used to stop the reaction. Cells were
extensively washed and then solubilized with cold 90%
methanol. The cells were labeled with PerCP CD3 (BD
Pharmingen, San Diego, CA) and FITC phospho-CD247
(GenWay Bio, San Diego, CA) fluorescently labeled anti-
bodies. Flow cytometry data acquisition and analysis
were performed on LSR II using FACS Diva software
(BD Pharmingen, San Diego, CA).
T cell IFN-g Production
Samples were stimulated with soluble anti-CD3 (Clone:
UCHT1; BD Pharmingen, San Diego, CA) and anti-
CD28 (Clone: CD28.2; BD Pharmingen, San Diego, CA)
and cross-linked with secondary antibody for 48 hours.
Culture supernatants were analyzed by ELISA for deter-
mination of IFN-g (Peprotech, Rocky Hill, NJ).
Statistical Analyses
Statistical comparisons were performed using either Stu-
dent T Test or one-way ANOVA with Holm-Sidak
post-hoc test utilizing SigmaStat 3.5 (Inspire Software
International, Ashburn, VA). The mean and standard
error of the mean were calculated in experiments with
multiple data points. A value of P ≤ 0.05 was considered
statistically significant.
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